Trial Profile
Randomised, double-blind, multicentre study evaluating the efficacy and tolerability of trantinterol versus procaterol in patients with mild to moderate chronic bronchial asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Sep 2021
Price :
$35
*
At a glance
- Drugs Trantinterol (Primary) ; Procaterol
- Indications Asthma
- Focus Therapeutic Use
- 25 Nov 2015 New trial record